RTT News, NY -6/29/2007 12:56:25 PM Friday, Cyclacel Pharmaceuticals Inc. (CYCC, CYCCP) said it began a Phase-I pharmacologic clinical study of CYC116, which is an orally ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=CTU&client=news" class="rich">CTU</a><a href="http://www.mmm-online.com/Shire-gearing-up-for-Vyvanse-launch/article/24295/" id=r-3_1117652548>Shire gearing up for Vyvanse launch</a><br>Medical Marketing and Media, NY - 27 minutes ago<br>Shire developed Vyvanse with New River Pharmaceuticals. Shire acquired New River in February in a deal worth $2.6 billion.

::Read the Full Article